|
|
hexose transmembrane transport
|
GO:0035428 |
7 |
1.000
|
|
|
|
anion transmembrane transport
|
GO:0098656 |
71 |
0.997
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.976
|
|
|
|
carnitine transmembrane transport
|
GO:1902603 |
3 |
0.976
|
|
|
|
regulation of renal output by angiotensin
|
GO:0002019 |
2 |
0.971
|
|
|
|
response to osmotic stress
|
GO:0006970 |
21 |
0.967
|
|
|
|
amino acid transmembrane transport
|
GO:0003333 |
37 |
0.922
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.918
|
|
|
|
anion transport
|
GO:0006820 |
177 |
0.918
|
|
|
|
renin angiotensin regulation of aldosterone production
|
GO:0002018 |
3 |
0.912
|
|
|
|
inorganic anion transmembrane transport
|
GO:0098661 |
29 |
0.906
|
|
|
|
carnitine transport
|
GO:0015879 |
3 |
0.891
|
|
|
|
renal tubule development
|
GO:0061326 |
87 |
0.863
|
|
|
|
vitamin transport
|
GO:0051180 |
10 |
0.861
|
|
|
|
fluid transport
|
GO:0042044 |
14 |
0.858
|
|
|
|
carbohydrate transport
|
GO:0008643 |
62 |
0.846
|
|
|
|
hydrogen ion transmembrane transport
|
GO:1902600 |
25 |
0.840
|
|
|
|
inorganic anion transport
|
GO:0015698 |
43 |
0.812
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.808
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.805
|
|
|
|
regulation of blood pressure
|
GO:0008217 |
93 |
0.805
|
|
|
|
regulation of activation of jak2 kinase activity
|
GO:0010534 |
1 |
0.793
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.790
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.778
|
|
|
|
amino acid betaine transport
|
GO:0015838 |
3 |
0.778
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.757
|
|
|
|
glucose transport
|
GO:0015758 |
56 |
0.756
|
|
|
|
positive regulation of transforming growth factor beta secretion
|
GO:2001203 |
1 |
0.734
|
|
|
|
renal system process
|
GO:0003014 |
48 |
0.733
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.731
|
|
|
|
organic anion transport
|
GO:0015711 |
137 |
0.729
|
|
|
|
activation of nf kappab inducing kinase activity
|
GO:0007250 |
4 |
0.711
|
|
|
|
activation of janus kinase activity
|
GO:0042976 |
2 |
0.669
|
|
|
|
water transport
|
GO:0006833 |
12 |
0.662
|
|
|
|
histamine uptake
|
GO:0051615 |
1 |
0.624
|
|
|
|
urate transport
|
GO:0015747 |
1 |
0.619
|
|
|
|
regulation of ph
|
GO:0006885 |
26 |
0.588
|
|
|
|
renal system process involved in regulation of systemic arterial blood pressure
|
GO:0003071 |
15 |
0.541
|
|
|
|
hexose transport
|
GO:0008645 |
56 |
0.533
|
|
|
|
regulation of systemic arterial blood pressure mediated by a chemical signal
|
GO:0003044 |
33 |
0.505
|
|
|
|
regulation of systemic arterial blood pressure by circulatory renin angiotensin
|
GO:0001991 |
13 |
0.496
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.495
|
|
|
|
bicarbonate transport
|
GO:0015701 |
7 |
0.495
|
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.473
|
|
|
|
regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator
|
GO:1902238 |
1 |
0.463
|
|
|
|
regulation of systemic arterial blood pressure by hormone
|
GO:0001990 |
25 |
0.462
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.455
|
|
|
|
carboxylic acid transport
|
GO:0046942 |
100 |
0.455
|
|
|
|
response to fructose
|
GO:0009750 |
2 |
0.449
|
|
|
|
monovalent inorganic cation homeostasis
|
GO:0055067 |
33 |
0.442
|
|
|
|
urea transmembrane transport
|
GO:0071918 |
2 |
0.432
|
|
|
|
steroid metabolic process
|
GO:0008202 |
119 |
0.431
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.426
|
|
|
|
regulation of systemic arterial blood pressure by renin angiotensin
|
GO:0003081 |
20 |
0.408
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.408
|
|
|
|
monosaccharide transport
|
GO:0015749 |
58 |
0.403
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.399
|
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.393
|
|
|
|
carbohydrate transmembrane transport
|
GO:0034219 |
10 |
0.385
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.383
|
|
|
|
progesterone metabolic process
|
GO:0042448 |
4 |
0.373
|
|
|
|
regulation of phospholipase a2 activity
|
GO:0032429 |
3 |
0.357
|
|
|
|
ureteric bud development
|
GO:0001657 |
94 |
0.344
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.337
|
|
|
|
modified amino acid transport
|
GO:0072337 |
5 |
0.333
|
|
|
|
sodium ion transport
|
GO:0006814 |
73 |
0.330
|
|
|
|
vasodilation
|
GO:0042311 |
28 |
0.328
|
|
|
|
intestinal absorption
|
GO:0050892 |
13 |
0.326
|
|
|
|
cellular response to insulin stimulus
|
GO:0032869 |
78 |
0.326
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.322
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.314
|
|
|
|
amino acid betaine metabolic process
|
GO:0006577 |
7 |
0.309
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.305
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.293
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.292
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.290
|
|
|
|
intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator
|
GO:1990127 |
1 |
0.288
|
|
|
|
chloride transport
|
GO:0006821 |
32 |
0.285
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.271
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.267
|
|
|
|
negative regulation of peptidyl serine phosphorylation
|
GO:0033137 |
10 |
0.267
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.263
|
|
|
|
endocrine process
|
GO:0050886 |
39 |
0.260
|
|
|
|
drinking behavior
|
GO:0042756 |
5 |
0.260
|
|
|
|
peptidyl serine phosphorylation
|
GO:0018105 |
74 |
0.254
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.253
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.252
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.250
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.244
|
|
|
|
cellular response to extracellular stimulus
|
GO:0031668 |
81 |
0.241
|
|
|
|
amino acid transport
|
GO:0006865 |
61 |
0.239
|
|
|
|
l amino acid transport
|
GO:0015807 |
32 |
0.239
|
|
|
|
regulation of neurotrophin trk receptor signaling pathway
|
GO:0051386 |
4 |
0.232
|
|
|
|
cellular response to peptide
|
GO:1901653 |
92 |
0.232
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.231
|
|
|
|
negative regulation of smooth muscle cell apoptotic process
|
GO:0034392 |
1 |
0.229
|
|
|
|
cell growth involved in cardiac muscle cell development
|
GO:0061049 |
3 |
0.228
|
|
|
|
regulation of transforming growth factor beta secretion
|
GO:2001201 |
1 |
0.223
|
|
|
|
positive regulation of reactive oxygen species metabolic process
|
GO:2000379 |
11 |
0.222
|
|
|
|
camera type eye photoreceptor cell differentiation
|
GO:0060219 |
15 |
0.222
|
|
|
|
urea transport
|
GO:0015840 |
4 |
0.220
|
|
|
|
mesonephric tubule morphogenesis
|
GO:0072171 |
63 |
0.220
|
|
|
|
cellular response to peptide hormone stimulus
|
GO:0071375 |
92 |
0.219
|
|
|
|
mesonephric tubule development
|
GO:0072164 |
94 |
0.216
|
|
|
|
eye photoreceptor cell differentiation
|
GO:0001754 |
41 |
0.214
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.213
|
|
|
|
ovulation
|
GO:0030728 |
15 |
0.213
|
|
|
|
regulation of blood volume by renin angiotensin
|
GO:0002016 |
7 |
0.212
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.210
|
|
|
|
regulation of blood circulation
|
GO:1903522 |
93 |
0.209
|
|
|
|
regulation of protein tyrosine kinase activity
|
GO:0061097 |
17 |
0.208
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.203
|
|
|
|
regulation of systemic arterial blood pressure
|
GO:0003073 |
61 |
0.199
|
|
|
|
fat soluble vitamin catabolic process
|
GO:0042363 |
1 |
0.196
|
|
|
|
limb development
|
GO:0060173 |
166 |
0.195
|
|
|
|
angiotensin activated signaling pathway
|
GO:0038166 |
4 |
0.192
|
|
|
|
alcohol metabolic process
|
GO:0006066 |
116 |
0.190
|
|
|
|
proton transport
|
GO:0015992 |
35 |
0.183
|
|
|
|
reactive oxygen species biosynthetic process
|
GO:1903409 |
8 |
0.179
|
|
|
|
purine containing compound biosynthetic process
|
GO:0072522 |
70 |
0.179
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.179
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.176
|
|
|
|
physiological cardiac muscle hypertrophy
|
GO:0003301 |
3 |
0.176
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.171
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.165
|
|
|
|
transforming growth factor beta secretion
|
GO:0038044 |
1 |
0.163
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.162
|
|
|
|
organic hydroxy compound transport
|
GO:0015850 |
93 |
0.162
|
|
|
|
bile acid and bile salt transport
|
GO:0015721 |
5 |
0.162
|
|
|
|
carnitine metabolic process
|
GO:0009437 |
7 |
0.158
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.154
|
|
|
|
regulation of renal sodium excretion
|
GO:0035813 |
3 |
0.153
|
|
|
|
excretion
|
GO:0007588 |
22 |
0.152
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.152
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.150
|
|
|
|
histamine transport
|
GO:0051608 |
2 |
0.149
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.148
|
|
|
|
hydrogen transport
|
GO:0006818 |
35 |
0.148
|
|
|
|
nephron tubule morphogenesis
|
GO:0072078 |
68 |
0.147
|
|
|
|
positive regulation of metanephric glomerulus development
|
GO:0072300 |
4 |
0.144
|
|
|
|
regulation of blood volume by renal aldosterone
|
GO:0002017 |
1 |
0.144
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.143
|
|
|
|
renal sodium excretion
|
GO:0035812 |
3 |
0.143
|
|
|
|
vasoconstriction
|
GO:0042310 |
27 |
0.141
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.141
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.140
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.137
|
|
|
|
mammary gland morphogenesis
|
GO:0060443 |
54 |
0.135
|
|
|
|
regulation of heart contraction
|
GO:0008016 |
77 |
0.134
|
|
|
|
positive regulation of mesonephros development
|
GO:0061213 |
20 |
0.134
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.134
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.133
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.131
|
|
|
|
response to starvation
|
GO:0042594 |
65 |
0.130
|
|
|
|
regulation of branching involved in ureteric bud morphogenesis
|
GO:0090189 |
22 |
0.130
|
|
|
|
negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress
|
GO:1902219 |
1 |
0.130
|
|
|
|
ureteric bud morphogenesis
|
GO:0060675 |
62 |
0.129
|
|
|
|
cellular response to fructose stimulus
|
GO:0071332 |
2 |
0.124
|
|
|
|
negative regulation of neurotrophin trk receptor signaling pathway
|
GO:0051387 |
2 |
0.122
|
|
|
|
norepinephrine transport
|
GO:0015874 |
2 |
0.121
|
|
|
|
nephron epithelium development
|
GO:0072009 |
92 |
0.121
|
|
|
|
neuron apoptotic process
|
GO:0051402 |
142 |
0.118
|
|
|
|
response to vitamin d
|
GO:0033280 |
3 |
0.117
|
|
|
|
cellular response to nutrient levels
|
GO:0031669 |
64 |
0.117
|
|
|
|
response to drug
|
GO:0042493 |
75 |
0.115
|
|
|
|
response to corticosterone
|
GO:0051412 |
1 |
0.114
|
|
|
|
development of primary male sexual characteristics
|
GO:0046546 |
88 |
0.114
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.113
|
|
|
|
kidney epithelium development
|
GO:0072073 |
121 |
0.113
|
|
|
|
dehydroascorbic acid transport
|
GO:0070837 |
3 |
0.112
|
|
|
|
positive regulation of reactive oxygen species biosynthetic process
|
GO:1903428 |
2 |
0.112
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
126 |
0.111
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.111
|
|
|
|
intrinsic apoptotic signaling pathway in response to osmotic stress
|
GO:0008627 |
2 |
0.110
|
|
|
|
renal sodium ion transport
|
GO:0003096 |
2 |
0.108
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.108
|
|
|
|
kidney morphogenesis
|
GO:0060993 |
83 |
0.108
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.108
|
|
|
|
potassium ion transmembrane transport
|
GO:0071805 |
43 |
0.107
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.107
|
|
|
|
carbohydrate biosynthetic process
|
GO:0016051 |
74 |
0.107
|
|
|
|
phospholipase c activating angiotensin activated signaling pathway
|
GO:0086097 |
1 |
0.104
|
|
|
|
negative regulation of ion transport
|
GO:0043271 |
28 |
0.104
|
|
|
|
erk1 and erk2 cascade
|
GO:0070371 |
77 |
0.103
|
|
|
|
establishment of protein localization to organelle
|
GO:0072594 |
118 |
0.103
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.103
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.102
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
40 |
0.101
|
|
|
|
brown fat cell differentiation
|
GO:0050873 |
36 |
0.099
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.099
|
|
|
|
regulation of protein secretion
|
GO:0050708 |
82 |
0.098
|
|
|
|
regulation of phospholipase c activity
|
GO:1900274 |
3 |
0.098
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.098
|
|
|
|
cellular response to osmotic stress
|
GO:0071470 |
7 |
0.098
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.097
|
|
|
|
reactive nitrogen species metabolic process
|
GO:2001057 |
0 |
0.097
|
|
|
|
organic acid transport
|
GO:0015849 |
101 |
0.097
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.096
|
|
|
|
neuropeptide signaling pathway
|
GO:0007218 |
19 |
0.095
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.094
|
|
|
|
positive regulation of blood pressure
|
GO:0045777 |
21 |
0.093
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.091
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.090
|
|
|
|
jak stat cascade
|
GO:0007259 |
42 |
0.090
|
|
|
|
response to activity
|
GO:0014823 |
13 |
0.090
|
|
|
|
regulation of protein maturation
|
GO:1903317 |
96 |
0.090
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.090
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.088
|
|
|
|
regulation of reactive oxygen species biosynthetic process
|
GO:1903426 |
2 |
0.088
|
|
|
|
potassium ion homeostasis
|
GO:0055075 |
4 |
0.087
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.087
|
|
|
|
male sex differentiation
|
GO:0046661 |
109 |
0.086
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.086
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.086
|
|
|
|
camp metabolic process
|
GO:0046058 |
40 |
0.086
|
|
|
|
regulation of tube size
|
GO:0035150 |
57 |
0.086
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.084
|
|
|
|
nephron morphogenesis
|
GO:0072028 |
69 |
0.083
|
|
|
|
nitric oxide biosynthetic process
|
GO:0006809 |
25 |
0.081
|
|
|
|
cognition
|
GO:0050890 |
149 |
0.081
|
|
|
|
regulation of ion transmembrane transporter activity
|
GO:0032412 |
54 |
0.080
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.079
|
|
|
|
negative regulation of blood pressure
|
GO:0045776 |
22 |
0.079
|
|
|
|
peptide transport
|
GO:0015833 |
133 |
0.079
|
|
|
|
regulation of transmission of nerve impulse
|
GO:0051969 |
1 |
0.079
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.077
|
|
|
|
mesonephric epithelium development
|
GO:0072163 |
94 |
0.076
|
|
|
|
negative regulation of heart rate
|
GO:0010459 |
4 |
0.075
|
|
|
|
peptide hormone processing
|
GO:0016486 |
9 |
0.075
|
|
|
|
positive regulation of phospholipase activity
|
GO:0010518 |
3 |
0.075
|
|
|
|
pallium development
|
GO:0021543 |
120 |
0.074
|
|
|
|
gliogenesis
|
GO:0042063 |
141 |
0.074
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.074
|
|
|
|
nik nf kappab signaling
|
GO:0038061 |
14 |
0.073
|
|
|
|
regulation of cholesterol esterification
|
GO:0010872 |
2 |
0.073
|
|
|
|
response to water deprivation
|
GO:0009414 |
1 |
0.073
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.073
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.072
|
|
|
|
regulation of peptidyl serine phosphorylation
|
GO:0033135 |
39 |
0.072
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.071
|
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.069
|
|
|
|
regulation of intrinsic apoptotic signaling pathway in response to osmotic stress
|
GO:1902218 |
1 |
0.069
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.068
|
|
|
|
neurotransmitter uptake
|
GO:0001504 |
14 |
0.068
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.067
|
|
|
|
regulation of metal ion transport
|
GO:0010959 |
106 |
0.067
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.067
|
|
|
|
hippocampus development
|
GO:0021766 |
52 |
0.067
|
|
|
|
neurotransmitter transport
|
GO:0006836 |
76 |
0.067
|
|
|
|
regulation of glomerulus development
|
GO:0090192 |
6 |
0.066
|
|
|
|
vitamin d catabolic process
|
GO:0042369 |
1 |
0.066
|
|
|
|
peptidyl serine modification
|
GO:0018209 |
83 |
0.066
|
|
|
|
insulin receptor signaling pathway
|
GO:0008286 |
49 |
0.065
|
|
|
|
hindbrain development
|
GO:0030902 |
128 |
0.065
|
|
|
|
vitamin metabolic process
|
GO:0006766 |
23 |
0.063
|
|
|
|
wnt signaling pathway involved in somitogenesis
|
GO:0090244 |
4 |
0.062
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.062
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.062
|
|
|
|
heart process
|
GO:0003015 |
94 |
0.062
|
|
|
|
heart contraction
|
GO:0060047 |
93 |
0.062
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.061
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.061
|
|
|
|
negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator
|
GO:1902239 |
1 |
0.061
|
|
|
|
negative regulation of wnt signaling pathway involved in heart development
|
GO:0003308 |
4 |
0.061
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.060
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.060
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.059
|
|
|
|
ovulation cycle
|
GO:0042698 |
59 |
0.059
|
|
|
|
one carbon compound transport
|
GO:0019755 |
5 |
0.058
|
|
|
|
neurological system process involved in regulation of systemic arterial blood pressure
|
GO:0001976 |
18 |
0.058
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.058
|
|
|
|
response to monosaccharide
|
GO:0034284 |
67 |
0.058
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.057
|
|
|
|
cellular response to monosaccharide stimulus
|
GO:0071326 |
47 |
0.057
|
|
|
|
histamine induced gastric acid secretion
|
GO:0001697 |
1 |
0.057
|
|
|
|
mesonephros development
|
GO:0001823 |
97 |
0.057
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.057
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.056
|
|
|
|
regulation of thyroid hormone generation
|
GO:2000609 |
4 |
0.056
|
|
|
|
cell proliferation in hindbrain
|
GO:0021534 |
10 |
0.056
|
|
|
|
lateral line system development
|
GO:0048925 |
1 |
0.055
|
|
|
|
renal system process involved in regulation of blood volume
|
GO:0001977 |
4 |
0.054
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.053
|
|
|
|
midgut development
|
GO:0007494 |
4 |
0.053
|
|
|
|
regulation of insulin receptor signaling pathway
|
GO:0046626 |
21 |
0.052
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.052
|
|
|
|
regulation of vasculature development
|
GO:1901342 |
88 |
0.051
|
|
|
|
hormone metabolic process
|
GO:0042445 |
86 |
0.051
|
|
|
|
positive regulation of inositol phosphate biosynthetic process
|
GO:0060732 |
2 |
0.051
|
|
|
|
regulation of muscle adaptation
|
GO:0043502 |
31 |
0.051
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.050
|
|
|
|
renal tubule morphogenesis
|
GO:0061333 |
72 |
0.050
|
|
|
|
establishment of blood nerve barrier
|
GO:0008065 |
3 |
0.050
|
|
|
|
female gamete generation
|
GO:0007292 |
74 |
0.049
|
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.049
|
|
|
|
rhombomere 5 development
|
GO:0021571 |
4 |
0.049
|
|
|
|
cellular response to abiotic stimulus
|
GO:0071214 |
56 |
0.049
|
|
|
|
positive regulation of vasoconstriction
|
GO:0045907 |
4 |
0.049
|
|
|
|
purine nucleotide biosynthetic process
|
GO:0006164 |
65 |
0.049
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.049
|
|
|
|
cellular response to oxidative stress
|
GO:0034599 |
76 |
0.049
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.048
|
|
|
|
positive regulation of cytosolic calcium ion concentration
|
GO:0007204 |
65 |
0.048
|
|
|
|
regulation of kidney development
|
GO:0090183 |
40 |
0.048
|
|
|
|
negative regulation of growth
|
GO:0045926 |
99 |
0.047
|
|
|
|
regulation of transmembrane transport
|
GO:0034762 |
128 |
0.046
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.046
|
|
|
|
mammary gland epithelium development
|
GO:0061180 |
65 |
0.046
|
|
|
|
negative regulation of lipid metabolic process
|
GO:0045833 |
30 |
0.046
|
|
|
|
regulation of angiogenesis
|
GO:0045765 |
81 |
0.046
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.046
|
|
|
|
regulation of cytokine secretion
|
GO:0050707 |
61 |
0.045
|
|
|
|
vasodilation by angiotensin involved in regulation of systemic arterial blood pressure
|
GO:0002033 |
2 |
0.045
|
|
|
|
monoamine transport
|
GO:0015844 |
33 |
0.045
|
|
|
|
photoreceptor cell differentiation
|
GO:0046530 |
52 |
0.045
|
|
|
|
erbb signaling pathway
|
GO:0038127 |
32 |
0.045
|
|
|
|
regulation of intracellular ph
|
GO:0051453 |
11 |
0.045
|
|
|
|
positive regulation of fibroblast proliferation
|
GO:0048146 |
20 |
0.044
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.044
|
|
|
|
regulation of peptide secretion
|
GO:0002791 |
77 |
0.043
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.043
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.043
|
|
|
|
adenylate cyclase activating g protein coupled receptor signaling pathway
|
GO:0007189 |
30 |
0.042
|
|
|
|
acylglycerol metabolic process
|
GO:0006639 |
55 |
0.042
|
|
|
|
regulation of activation of janus kinase activity
|
GO:0010533 |
1 |
0.042
|
|
|
|
positive regulation of nitric oxide biosynthetic process
|
GO:0045429 |
14 |
0.042
|
|
|
|
trachea cartilage morphogenesis
|
GO:0060535 |
4 |
0.042
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.041
|
|
|
|
muscle cell proliferation
|
GO:0033002 |
52 |
0.041
|
|
|
|
regulation of angiotensin metabolic process
|
GO:0060177 |
4 |
0.041
|
|
|
|
regulation of cellular carbohydrate metabolic process
|
GO:0010675 |
75 |
0.041
|
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.041
|
|
|
|
regulation of protein kinase c activity
|
GO:1900019 |
1 |
0.041
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.040
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.040
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.040
|
|
|
|
mammary gland duct morphogenesis
|
GO:0060603 |
38 |
0.039
|
|
|
|
protein secretion
|
GO:0009306 |
111 |
0.039
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.039
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.039
|
|
|
|
regulation of norepinephrine secretion
|
GO:0014061 |
2 |
0.039
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.039
|
|
|
|
regulation of osteoblast differentiation
|
GO:0045667 |
67 |
0.039
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.039
|
|
|
|
regulation of cellular ph
|
GO:0030641 |
12 |
0.038
|
|
|
|
purine ribonucleoside biosynthetic process
|
GO:0046129 |
19 |
0.038
|
|
|
|
dicarboxylic acid transport
|
GO:0006835 |
29 |
0.038
|
|
|
|
tissue migration
|
GO:0090130 |
68 |
0.038
|
|
|
|
nephron epithelium morphogenesis
|
GO:0072088 |
68 |
0.038
|
|
|
|
c21 steroid hormone metabolic process
|
GO:0008207 |
7 |
0.038
|
|
|
|
cellular response to starvation
|
GO:0009267 |
57 |
0.038
|
|
|
|
cellular response to hexose stimulus
|
GO:0071331 |
47 |
0.038
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.038
|
|
|
|
retinal cell programmed cell death
|
GO:0046666 |
8 |
0.038
|
|
|
|
cyclic purine nucleotide metabolic process
|
GO:0052652 |
43 |
0.038
|
|
|
|
glomerulus development
|
GO:0032835 |
40 |
0.038
|
|
|
|
cochlear nucleus development
|
GO:0021747 |
4 |
0.038
|
|
|
|
planar cell polarity pathway involved in outflow tract morphogenesis
|
GO:0061347 |
2 |
0.037
|
|
|
|
renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure
|
GO:0003072 |
5 |
0.037
|
|
|
|
c21 steroid hormone biosynthetic process
|
GO:0006700 |
3 |
0.037
|
|
|
|
response to insulin
|
GO:0032868 |
100 |
0.037
|
|
|
|
cardiocyte differentiation
|
GO:0035051 |
87 |
0.037
|
|
|
|
positive regulation of camp mediated signaling
|
GO:0043950 |
3 |
0.037
|
|
|
|
positive regulation of renal sodium excretion
|
GO:0035815 |
2 |
0.036
|
|
|
|
striated muscle contraction
|
GO:0006941 |
45 |
0.036
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.036
|
|
|
|
positive regulation of insulin receptor signaling pathway
|
GO:0046628 |
4 |
0.036
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.035
|
|
|
|
disruption of cells of other organism involved in symbiotic interaction
|
GO:0051818 |
13 |
0.035
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.035
|
|
|
|
sulfur compound transport
|
GO:0072348 |
9 |
0.035
|
|
|
|
response to water
|
GO:0009415 |
1 |
0.035
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.035
|
|
|
|
forebrain neuron development
|
GO:0021884 |
30 |
0.035
|
|
|
|
regulation of microvillus organization
|
GO:0032530 |
3 |
0.035
|
|
|
|
glucose metabolic process
|
GO:0006006 |
92 |
0.035
|
|
|
|
regulation of protein processing
|
GO:0070613 |
96 |
0.035
|
|
|
|
cardiac right atrium morphogenesis
|
GO:0003213 |
3 |
0.035
|
|
|
|
fat soluble vitamin metabolic process
|
GO:0006775 |
11 |
0.035
|
|
|
|
cellular response to steroid hormone stimulus
|
GO:0071383 |
33 |
0.035
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.034
|
|
|
|
response to alcohol
|
GO:0097305 |
48 |
0.034
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.034
|
|
|
|
positive regulation of branching involved in ureteric bud morphogenesis
|
GO:0090190 |
18 |
0.034
|
|
|
|
retina vasculature development in camera type eye
|
GO:0061298 |
17 |
0.034
|
|
|
|
peptide secretion
|
GO:0002790 |
114 |
0.034
|
|
|
|
hormone mediated signaling pathway
|
GO:0009755 |
23 |
0.034
|
|
|
|
ovulation from ovarian follicle
|
GO:0001542 |
9 |
0.034
|
|
|
|
vasodilation by norepinephrine epinephrine involved in regulation of systemic arterial blood pressure
|
GO:0002025 |
3 |
0.034
|
|
|
|
cerebellar granule cell precursor proliferation
|
GO:0021930 |
10 |
0.034
|
|
|
|
canonical wnt signaling pathway involved in regulation of cell proliferation
|
GO:0044340 |
3 |
0.033
|
|
|
|
cyclic nucleotide metabolic process
|
GO:0009187 |
59 |
0.033
|
|
|
|
ribose phosphate biosynthetic process
|
GO:0046390 |
59 |
0.033
|
|
|
|
fertilization
|
GO:0009566 |
127 |
0.033
|
|
|
|
positive regulation of protein secretion
|
GO:0050714 |
52 |
0.033
|
|
|
|
regulation of long term neuronal synaptic plasticity
|
GO:0048169 |
19 |
0.033
|
|
|
|
axis elongation
|
GO:0003401 |
30 |
0.033
|
|
|
|
regulation of blood vessel size
|
GO:0050880 |
56 |
0.033
|
|
|
|
monocarboxylic acid biosynthetic process
|
GO:0072330 |
61 |
0.032
|
|
|
|
monosaccharide metabolic process
|
GO:0005996 |
106 |
0.032
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.032
|
|
|
|
metencephalon development
|
GO:0022037 |
89 |
0.032
|
|
|
|
phosphatidylinositol mediated signaling
|
GO:0048015 |
41 |
0.032
|
|
|
|
regulation of superoxide anion generation
|
GO:0032928 |
4 |
0.032
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.032
|
|
|
|
regulation of ion homeostasis
|
GO:2000021 |
64 |
0.032
|
|
|
|
regulation of multi organism process
|
GO:0043900 |
111 |
0.031
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.031
|
|
|
|
regulation of glycogen metabolic process
|
GO:0070873 |
13 |
0.031
|
|
|
|
cardiac muscle cell development
|
GO:0055013 |
39 |
0.031
|
|
|
|
sodium ion transmembrane transport
|
GO:0035725 |
49 |
0.031
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.031
|
|
|
|
adenylate cyclase modulating g protein coupled receptor signaling pathway
|
GO:0007188 |
54 |
0.031
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.031
|
|
|
|
negative regulation of cellular carbohydrate metabolic process
|
GO:0010677 |
19 |
0.031
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.031
|
|
|
|
regulation of ion transmembrane transport
|
GO:0034765 |
119 |
0.030
|
|
|
|
limb morphogenesis
|
GO:0035108 |
149 |
0.030
|
|
|
|
metanephric loop of henle development
|
GO:0072236 |
4 |
0.030
|
|
|
|
adult locomotory behavior
|
GO:0008344 |
91 |
0.030
|
|
|
|
organic acid biosynthetic process
|
GO:0016053 |
86 |
0.030
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.030
|
|
|
|
positive regulation of phospholipase c activity
|
GO:0010863 |
2 |
0.030
|
|
|
|
energy reserve metabolic process
|
GO:0006112 |
39 |
0.030
|
|
|
|
digestion
|
GO:0007586 |
40 |
0.030
|
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
118 |
0.030
|
|
|
|
interleukin 10 secretion
|
GO:0072608 |
4 |
0.030
|
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
119 |
0.030
|
|
|
|
androgen biosynthetic process
|
GO:0006702 |
4 |
0.030
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.030
|
|
|
|
l glutamate transport
|
GO:0015813 |
16 |
0.030
|
|
|
|
renal response to blood flow involved in circulatory renin angiotensin regulation of systemic arterial blood pressure
|
GO:0001999 |
6 |
0.030
|
|
|
|
symbiosis encompassing mutualism through parasitism
|
GO:0044403 |
83 |
0.029
|
|
|
|
positive regulation of extracellular matrix organization
|
GO:1903055 |
4 |
0.029
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.029
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
147 |
0.029
|
|
|
|
retina vasculature morphogenesis in camera type eye
|
GO:0061299 |
10 |
0.029
|
|
|
|
nucleotide biosynthetic process
|
GO:0009165 |
78 |
0.029
|
|
|
|
activation of phospholipase c activity
|
GO:0007202 |
2 |
0.029
|
|
|
|
ventricular cardiac muscle cell action potential
|
GO:0086005 |
4 |
0.028
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.028
|
|
|
|
regulation of peptide transport
|
GO:0090087 |
91 |
0.028
|
|
|
|
regulation of kidney size
|
GO:0035564 |
3 |
0.028
|
|
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.028
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
96 |
0.028
|
|
|
|
negative regulation of sterol transport
|
GO:0032372 |
4 |
0.028
|
|
|
|
cell cell adhesion
|
GO:0098609 |
41 |
0.028
|
|
|
|
positive regulation of blood circulation
|
GO:1903524 |
22 |
0.028
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
155 |
0.028
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.028
|
|
|
|
physiological muscle hypertrophy
|
GO:0003298 |
3 |
0.028
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.028
|
|
|
|
embryonic appendage morphogenesis
|
GO:0035113 |
126 |
0.027
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.027
|
|
|
|
mineralocorticoid biosynthetic process
|
GO:0006705 |
1 |
0.027
|
|
|
|
cardiac muscle cell differentiation
|
GO:0055007 |
69 |
0.027
|
|
|
|
retina development in camera type eye
|
GO:0060041 |
119 |
0.027
|
|
|
|
positive regulation of cytokine secretion
|
GO:0050715 |
41 |
0.027
|
|
|
|
regulation of neurotransmitter levels
|
GO:0001505 |
87 |
0.027
|
|
|
|
sterol metabolic process
|
GO:0016125 |
58 |
0.026
|
|
|
|
drug catabolic process
|
GO:0042737 |
2 |
0.026
|
|
|
|
drug metabolic process
|
GO:0017144 |
4 |
0.026
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.026
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.026
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.026
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.026
|
|
|
|
cellular potassium ion transport
|
GO:0071804 |
43 |
0.026
|
|
|
|
regulation of inositol phosphate biosynthetic process
|
GO:0010919 |
3 |
0.026
|
|
|
|
cellular response to carbohydrate stimulus
|
GO:0071322 |
50 |
0.026
|
|
|
|
hepatic duct development
|
GO:0061011 |
1 |
0.026
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
87 |
0.026
|
|
|
|
phospholipid metabolic process
|
GO:0006644 |
87 |
0.026
|
|
|
|
learning or memory
|
GO:0007611 |
148 |
0.026
|
|
|
|
norepinephrine secretion
|
GO:0048243 |
2 |
0.026
|
|
|
|
negative regulation of peptidase activity
|
GO:0010466 |
46 |
0.026
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.026
|
|
|
|
sperm capacitation
|
GO:0048240 |
17 |
0.025
|
|
|
|
cofactor metabolic process
|
GO:0051186 |
80 |
0.025
|
|
|
|
regulation of inward rectifier potassium channel activity
|
GO:1901979 |
1 |
0.025
|
|
|
|
potassium ion import
|
GO:0010107 |
1 |
0.025
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.025
|
|
|
|
lipid transport
|
GO:0006869 |
98 |
0.025
|
|
|
|
cellular response to prostaglandin stimulus
|
GO:0071379 |
2 |
0.025
|
|
|
|
fatty acid metabolic process
|
GO:0006631 |
121 |
0.025
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.025
|
|
|
|
planar cell polarity pathway involved in cardiac right atrium morphogenesis
|
GO:0061349 |
2 |
0.025
|
|
|
|
negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis
|
GO:2000149 |
1 |
0.025
|
|
